Pioneering phase 2 clinical trial for glioblastoma delivers initial results. While no survival breakthroughs yet, this groundbreaking adaptive platform trial brings hope for efficient therapy identification.
Follow Us On:
KYOTO, JAPAN
Global Marketing Association Co. Ltd,
8th Floor, ASTEM Bldg. Kyoto Research Park,
134 Chudoji Minamimachi, Shimogyo-ku, Kyoto-city,
KYOTO - 600883, JAPAN
support_japan@manuscriptedit.jp
www.manuscriptedit.jp
NC, DURHAM, USA
2530 Meridian Parkway, Suite 300,
Durham, NC, 27713, United States of America
MAIDSTONE, UK
26 Kings Hill Avenue, Kings Hill, West Malling,
Maidstone, ME19 4AE
BHUBANESWAR, INDIA
DCB-401,4th Floor,DLF Cyber City,
Chandaka Industrial Estate,Patia,
Bhubaneswar-751024, Odisha, INDIA
BANGALORE, INDIA
Level 9 Raheja Towers,
26-27 Mahatma Gandhi Road,
Bangalore-560 001, INDIA
© 2024 ManuscriptEdit. All Rights Reserved.
Refund & Cancellation / Privacy Policy / Terms & Conditions / Author Service agreement / Editor Service agreement